Startup CPG Newswire:
Trelli Announces April 2026 Launch with Relivaid, a Science-First Alternative to Conventional OTC Pain Relief

PRESS RELEASE — NEWS PROVIDED BY Luke Lundstrom for Trelli

NEW YORK, NY (APRIL 2026) — Trelli, a science-first company focused on naturally derived bioactives, is launching its debut product, Relivaid, on April 14, 2026, exclusively at trelli.health.

Relivaid is a fast-acting, single-dose pain support formula designed to deliver meaningful relief using naturally derived ingredients. While most products in the category rely on standard ingredient forms, Relivaid applies advanced delivery technologies to improve both bioavailability and speed of uptake.

The formula features a phospholipid-complexed PEA and a specialized ginger extract designed to enhance how quickly and effectively active compounds reach the bloodstream. The result is targeted support for tension headaches, menstrual cramps, joint and muscle aches, and general inflammation.

All Trelli formulations are developed in collaboration with a medical advisory board that includes physicians, researchers, registered dietitians, and biomolecular scientists, with affiliations spanning Harvard Medical School, Scripps Integrative Medicine, and prior research leadership at companies including Thorne.

“I built Trelli after years of relying on conventional OTC that triggered serious IBS flares,” said Luke Lundstrom, founder of Trelli. “When I went looking for an alternative that was designed for symptom relief, I couldn’t find a credible solution. Trelli was built to be the better-for-you replacement that still works.”

Relivaid will be available April 14, 2026 at trelli.health, marking the company’s entry into the consumer health market with a formulation approach that prioritizes both natural sourcing and pharmaceutical-level delivery.

About Trelli

Trelli is a science-first consumer health company developing better-for-you solutions designed for the medicine cabinet. Using clinically studied, naturally derived bioactives, Trelli formulations deliver fast-acting symptom relief with a focus on safety and tolerability.

Formulated alongside a team of physicians and integrative health experts, Trelli identifies bioactives found in nature and optimizes them through advanced delivery technology to maximize their relief profile. Every formula is grounded in human clinical research and engineered for single-dose efficacy.

Trelli is based in New York, NY. Learn more at trelli.health.

If your brand wants to publish a press release on the Startup CPG Newswire,  fill out the form here. 

The news and images contained on this page has been provided by a third party. Startup CPG does not verify, endorse, or vouch for any information or content submitted by third parties, or verify the identity, credentials, or expertise of third parties. We encourage you to consider carefully the source of all information and content provided by third parties on this website.

Join Startup CPG!

Have you joined our *free* Slack community yet? Join the largest CPG community in the world to receive and share on-the-spot advice, industry news and data, and exclusive discounts and opportunities for emerging brands.

If you want to be the first to know about key business updates from the most innovative early CPG brands, sign up for our bi-weekly Newswire roundups here.